GlassScriptPhysician profile
Jermania Estevez
NPI 1770593253
$3,475.10
in general payments reported to CMS, 2019-2025
23 companies · $44.78 in 2025
The $44.78 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $701 · 2020: $733 · 2021: $855 · 2022: $1,102 · 2024: $38.82 · 2025: $44.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,411.04 | 2019-2022 | |
| Abbvie INC. | $425.66 | 2019-2025 | |
| Allergan, INC. | $238.84 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $234.13 | 2019-2022 | |
| Lilly USA, LLC | $172.68 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $127.27 | 2022 | |
| Pfizer INC. | $124.47 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $117.99 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $85.69 | 2022 | |
| Amgen INC. | $75.77 | 2019-2022 | |
| Esperion Therapeutics, INC. | $71.11 | 2021 | |
| Exact Sciences Corporation | $67.53 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amarin Pharma, INC. | $65.41 | 2019-2021 | |
| Glaxosmithkline, LLC. | $56.73 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $44.56 | 2020-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33.02 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $22.87 | 2022 | |
| Merck Sharp & Dohme LLC | $22.52 | 2020 | |
| Alfasigma USA, INC. | $18.74 | 2020 | |
| Antares Pharma, INC. | $17.57 | 2022 | |
| Hologic Sales and Service, LLC | $14.44 | 2022 | |
| Janssen Pharmaceuticals, INC | $13.70 | 2019 | |
| Daiichi Sankyo INC. | $13.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jermania Estevez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.